were recorded for both suspensions, the deficiency caused by Lyb-2 depletion was 55-60%, in accord with published data (1, 4) .
ELIMINATION OF Lyt-2 + AND Thy-1 + CELLS. Lyt-2 + cells were eliminated from nylon-purified splenic T cells by one cycle of treatment as above, with a standard conventional Lyt-2.2 antiserum plus C (1:9) and cell counts were adjusted as above. The same procedure was used when eliminating Thy-1 + cells with monoclonal Thy-1.2 antibody (mc-a-Thy-1.2) (1 : 1,000).
Mishell-Dutton Culture. Spleen cells (1 × 107/ml) were cultured in RPMI-1640 (Grand Island Biological Co., Grand Island, N. Y.) containing 10% fetal bovine serum (FBS) (Microbiological Associates, Walkersville, Md.), L-glutamine (2 mM), streptomycin (100 #g/ml), penicillin (100 U/ml), 2-mercaptoethanol (5 X 10 -5 M), sodium pyruvate (1 mM), and Hepes buffer (10 mM), in 16-mm flat-bottomed plates (76-033-65; Linbro Chemical Co., Hamdem, Conn.) with SRBC (5 X 106), TNP-B. abortus (1:1,000 of stock) or TNP-Ficoll (1 ng/ml), with or without me-aLyb-2. i (1:50 unless otherwise stated), at 37°C in a humidified atmosphere of 10% CO2 without rocking. Cultures were fed daily with a mixture of 60 g.I nutritional cocktail (8) and 30 #1 FBS.
Plaque-forming Cell (PFC) Assay. PFC counts were determined on day 5 for anti-SRBC (unless otherwise stated), and on day 4 for anti-TNP response to T-independent antigen, respectively, by the slide modification (9) of the Jerne plaque assay. TNP was coupled to SRBC as described (10) . Results were expressed as PFC per culture or as the percent PFC response: = 100 [(PFC experiment)/(PFC control)].
Results and Discussion
Inhibition of Generation of Anti-SRBC PFC by Lyb-2 Antibody. Fig. 1 shows the PFC responses of cultures in which mc-c~-Lyb-2.1 was included throughout the 5-d culture period. PFC counts were reduced in proportion to the concentration of Lyb-2.1 antibody, the greatest reduction, 73%, occurring at the highest concentration of mcot-Lyb-2.1 tested, 1:50. Specificity for Lyb-2 is shown by the controls in which Lyb-2.1 antibody caused no reduction in PFC counts when B6 spleen cells (Lyb-2.2) were substituted for congenic B6-Lyb-2.1 spleen cells (Fig. 1) . FxG. I. Inhibition of generation ofanti-SRBC PFC by Lyb-2 antibody. 10 X l0 n B6-Lyb-2.1 or B6 (control) spleen cells were cultured with 5 X 10 n SRBC in the presence of mc-a-Lyb-2.1 throughout the euhure period. Anti-SRBC PFC were assayed on day 5. Control PFC counts (antibody omitted) were 1,543 zl: 233 for B6 and 1,618 4-189 for B6-Lyb-2.1 (standard 100% response for calculation of '~PFC response). Period of Action of Lyb-2 Antibody. Fig. 3 shows that mc-a-Lyb-2.1 was about onehalf as effective in reducing PFC counts when introduced after 24 h of culture, as compared with the first 12 h, and was ineffective after 3 d. Table I is concerned with the possibility that the cells on which Lyb-2 antibody acts, in lowering PFC generation, are not in fact B cells, but other cells whose Lyb-2 + phenotype has previously escaped serological detection. This question was approached first with cultures composed of B6 or B6-Lyb-2.1 splenic T cells (nylon purified) combined with B6-Lyb-2.1 or B6 Tdepleted spleen cells (mc-a-Thy-l.2 + C). Table I shows that PFC counts were reduced by me-a-Lyb-2.1 only when T-depleted spleen cells were Lyb-2.1, the Lyb-2 phenotype of the T cells being irrelevant. Thus the cells on which Lyb-2 antibody acts are not T cells.
Rate of PFC Generation in the Presence

Non-T Identity of Cells Affected by Lyb-2 Antibody.
Evidence against the Involvement of Suppression. The data above suggest that B cell precursors of AFC are inhibited by Lyb-2 antibody. Alternatively, Lyb-2 antibody might cause B cells to evoke suppression from T cells. But the data in Table II are against such a mechanism, because elimination of Lyt-2 + cells (removing not only the Ly23 T set to which T suppressors belong but also the antecedent Ly123 set) did not abolish reduction of PFC by Lyb-2 antibody. Full reduction occurred with no T cells other than the Lyl set.
The data in Fig. 4 substantially eliminate the further possibility that Lyb-2 antibody evokes B cell-mediated suppression: In this experiment, assays were conducted with unselected B6 and B6-Lyb-2.1 spleen cells combined in serial proportions. The reduction in PFC counts caused by mc-a-Lyb-2.1 was directly proportional to the number of B6-Lyb-2.1 cells present, a result that does not fit the idea of a released B cell product inducing suppression.
Generation of PFC from Lyb-2 Heterozygous Cells in the Presence of Lyb-2 Antibody.
One might argue that a reduction in PFC counts can be caused by attachment of antibody per se during the generation of PFC. The experiment illustrated in Table III speaks against this, for mc-a-Lyb-2.1 caused no reduction in PFC generated from Lyb-2.1/ Lyb-2.2 heterozygotes. This result may also imply that PFC reduction depends on blocking of at least most Lyb-2 sites. 
TAnLE III
Generation of PFC from Lyb-2 Heterozygous Cells in the Presence of Lyb-2 Antibody
PFC Response to T-independent Antigen in the Presence of Lyb-2 Antibody.
The following results concern responses to T-independent antigens. Choice of the two antigens TNP-B. abortus and TNP-Ficoll was based on evidence that they represent two categories of T-independent antigen, the former elicits a normal response in mutant B cell-deficient CBA/N mice and the latter does not (11) . Table IV signifies that mc-a-Lyb-2.1 did not impede the generation of PFC to either antigen. Because T-independent antigens can be potent stimulators of B cell differentiation, further cultures were set up, as above, and fed 20 #1 of mc-a-Lyb-2.1 daily to ensure a continuous sufficiency of Lyb-2 antibody to react with Lyb-2 + cells that might be recruited from Lyb-2-precursors during the culture period; but once again there was no inhibition of the PFC response (data not shown).
PFC Responses of Lyb-2-depleted Spleen Cells.
It remains to be asked whether the B cells that generate PFC to T-independent antigen and are not affected by Lyb-2 antibody (Table IV) are in fact Lyb-2 ÷. Table V answers that question. When the responding population is exposed to Lyb-2 antibody and C, rather than Lyb-2 antibody alone (thus eliminating Lyb-2 + cells), the PFC response to both T-independent and T-dependent antigens is equally reduced. We infer that the Lyb-2 molecule is present, but not required, on B cells responding to T-independent antigens.
Clearly, the Lyb-2 molecule is required for efficient generation of AFC in response to T-dependent antigen. Whether it is involved in the process of antigen recognition or in subsequent events, notably, perhaps, in differentiation induced by receipt of a signal from Ly 1 cells, remains to be seen. With regard to possible action of a-Lyb-2 on accessory cells, this is unlikely for macrophages generally, because the macrophage population as a whole does not express Lyb-2; nevertheless the possibility that antiLyb-2 might react with a minor accessory Lyb-2 + population that has escaped serological recognition is presently being studied by functional assay. In any event, Lyb-2 need not necessarily be envisaged as itself the receptor, for it might be part of a receptor molecular complex small enough to be obstructed by Lyb-2 antibody. Summary The Lyb-2 cell-surface alloantigens of the mouse are selectively and perhaps exclusively expressed in the B lymphocyte lineage, but not on antibody-forming cells. Thus if the Lyb-2 molecule is concerned in specific B cell function, it must participate in the generative phase of the antibody response.
Accordingly, monoclonal Lyb-2 antibody was found to depress the plaque-forming cell (PFC) response to sheep erythrocytes in 5-d Mishell-Dutton assays when added within the first 3 d of culture, but not later. The rate of PFC generation was not affected, signifying an absolute reduction in the number of PFC generated. Because reduction of PFC counts by Lyb-2 antibody was not affected by exclusion of Lyt-2 + T cells, it is unlikely that the reduction depends on augmented suppression by T cells. Augmented B cell-mediated suppression is also unlikely, because the PFC response of serial combinations of congenic Lyb-2.1 and Lyb-2.2 cells, in the presence of monoclonal Lyb-2.1 antibody, was reduced only in direct proportion to the number of Lyb-2.1 cells present. The PFC response of Lyb-2.1/Lyb-2.2 heterozygous cells was not reduced by Lyb-2.1 antibody, presumably because generation of PFC is impeded only if most Lyb-2 sites are blocked. Further evidence that the molecule identified by Lyb-2 plays a critical role in the generation of antibody-forming cells (AFC) in response to T-dependent antigen comes from the finding that Lyb-2 antibody does not reduce the PFC response to the T-independent antigens trinitrophenylated (TNP) Brucella abortus and TNP-FicolI, although elimination of Lyb-2 + cells from the starting population by Lyb-2 antibody and complement reduces the PFC response to Tdependent and T-independent antigens alike.
